Fig. 3From: Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trialKaplan–Meier curves of biochemical (A) and local (B) progression following radiotherapy. Nine (12.9% [95% CI: 6.1–23.0%]) and three (4.3% [95% CI: 0.9–12.0%]) patients had progressed biochemically and locally, respectively, three-years following treatmentBack to article page